18 May 2013
Keywords: troubled, development, glitazars, may, provide, opportunity, ddp-4
Article | 18 September 2006
A report highlighting the uncertain future of the a new class of antidabetic drugs - the glitazars, has been released ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 September 2006
17 May 2013
© 2013 thepharmaletter.com